Integrated CRDMO Solutions Across Advanced Modalities
CATUG supports programs across therapeutic modalities, whether delivering full end-to-end solutions or selected components such as plasmid DNA, RNA drug substance, or drug product manufacturing.
Offering plasmids featuring ≥95% supercoiled, ≥95% linearized forms, and endotoxin, RNase-free preparations.
mRNA/circRNA/saRNA production with high purity and consistent quality, from 0.1mg-45g.
Innovative process for single or multi-payload encapsulation and antibody-LNP conjugates.
Customizable solutions from research-grade to GMP-compliant, meeting diverse needs across discovery, IND, IIT, clinical, and commercial manufacturing.
Discovery / mRNA / saRNA / circRNA production with high purity and consistent quality.
CMC for IND /mRNA / saRNA / circRNA production with high purity and consistent quality.
CATUG is a technology-driven CRDMO platform for nucleic acid and advanced therapeutics, integrating DNA, RNA, LNP/tLNP delivery, protein/nanobody manufacturing, analytics, and GMP CMC execution to advance complex therapies from early research to clinical development.